Bull Creek, Australia

Rakesh N Veedu

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: University of Colorado. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rakesh N Veedu. Retrieved from https://idiyas.com/inventor/rakesh-n-veedu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rakesh N Veedu: Innovator in Muscular Dystrophy Treatment

Introduction

Rakesh N Veedu is a prominent inventor based in Bull Creek, Australia. He has made significant contributions to the field of medical research, particularly in the treatment of muscular dystrophy. His innovative approach focuses on utilizing antisense thiomorpholino oligonucleotides to address this debilitating condition.

Latest Patents

Rakesh N Veedu holds 1 patent for his work titled "Thiomorpholino oligonucleotides for the treatment of muscular dystrophy." This patent describes improved compositions and methods for treating muscular dystrophy through target exon skipping. By administering antisense thiomorpholino molecules that bind to a specific target site in the human dystrophin gene, he aims to induce exon skipping, ultimately producing a functional Dystrophin protein.

Career Highlights

Rakesh N Veedu is affiliated with the University of Colorado, where he continues to advance his research in genetic therapies. His work has garnered attention for its potential to transform the treatment landscape for muscular dystrophy patients.

Collaborations

He has collaborated with notable researchers, including Marvin H Caruthers and Sibasish Paul, to further enhance the impact of his innovations in the field.

Conclusion

Rakesh N Veedu's contributions to the treatment of muscular dystrophy through innovative patenting and research exemplify the potential of targeted genetic therapies. His work continues to inspire advancements in medical science and offers hope for those affected by this condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…